LeonaBio (LONA) Gains from Investment Securities (2019 - 2025)
LeonaBio (LONA) reported Gains from Investment Securities of $1.2 million for Q3 2025, down 70.34% year-over-year from $4.1 million in Q3 2024, and down 45.57% on a QoQ basis from $2.2 million in Q2 2025.
LeonaBio (LONA) has 7 years of Gains from Investment Securities data on file, last reported at $1.2 million in Q3 2025.
- Quarterly Gains from Investment Securities fell 70.34% year-over-year to $1.2 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $200000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $1.2 million, up 25.35% from the prior year.
- Gains from Investment Securities eased to $1.2 million in Q3 2025 per LONA's latest filing, from $2.2 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $4.3 million in Q3 2022 and bottomed at -$1.3 million in Q4 2021.
- The 5-year median for Gains from Investment Securities is $1.4 million (2025), against an average of $1.5 million.
- Peak annual rise in Gains from Investment Securities reached 2509810900.0% in 2021, while the deepest fall reached 99.82% in 2021.
- Tracing LONA's Gains from Investment Securities over 5 years: stood at -$1.3 million in 2021, then jumped by 426.37% to $4.3 million in 2022, then slumped by 85.38% to $629899.0 in 2023, then soared by 549.12% to $4.1 million in 2024, then plunged by 70.34% to $1.2 million in 2025.
- Per Business Quant, the three latest LONA Gains from Investment Securities figures stand at $1.2 million (Q3 2025), $2.2 million (Q2 2025), and $1.6 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Sep 30, 2024 | 4.09 Mn |
| Sep 30, 2024 | 4.09 Mn |
| Jun 30, 2024 | 50,566.00 |
| Jun 30, 2024 | 50,566.00 |
| Mar 31, 2024 | 39,216.00 |
| Mar 31, 2024 | 39,216.00 |
| Sep 30, 2023 | 629,899.00 |
| Sep 30, 2023 | 629,899.00 |
| Jun 30, 2023 | 2.66 Mn |
| Jun 30, 2023 | 2.66 Mn |
| Mar 31, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Sep 30, 2022 | 4.31 Mn |
| Sep 30, 2022 | 4.31 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | 2.70 Mn |
| Mar 31, 2022 | 2.70 Mn |
| Dec 31, 2021 | -1.32 Mn |
| Dec 31, 2021 | -1.32 Mn |
| Sep 30, 2021 | 658,776.00 |
| Sep 30, 2021 | 658,776.00 |
| Jun 30, 2021 | 2,400.00 |
| Jun 30, 2021 | 2,400.00 |
| Mar 31, 2021 | 2.51 Mn |
| Mar 31, 2021 | 2.51 Mn |
| Dec 31, 2020 | -8.00 Mn |
| Dec 31, 2020 | -8.00 Mn |
| Sep 30, 2020 | 41,301.00 |
| Sep 30, 2020 | 41,301.00 |
| Jun 30, 2020 | 1.30 Mn |
| Jun 30, 2020 | 1.30 Mn |
| Mar 31, 2020 | 0.10 |
| Mar 31, 2020 | 0.10 |
| Dec 31, 2019 | 35,000.00 |
| Dec 31, 2019 | 35,000.00 |